Page last updated: 2024-12-06

chelerythrine chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Chelerythrine chloride is a benzophenanthridine alkaloid found in plants like Chelidonium majus (greater celandine). It exhibits a broad range of pharmacological activities, including anti-inflammatory, antitumor, and anti-angiogenic properties. Research suggests that it acts as a protein kinase C (PKC) inhibitor, a crucial enzyme involved in cell signaling pathways. This inhibition of PKC is believed to contribute to its anti-cancer effects. The compound has been investigated for potential use in treating a variety of cancers, including leukemia, breast cancer, and lung cancer. However, due to its cytotoxic nature and potential side effects, its clinical use remains limited. Extensive research is ongoing to develop safer and more effective derivatives or formulations.'

Cross-References

ID SourceID
PubMed CID72311
CHEMBL ID258893
SCHEMBL ID195109
MeSH IDM0313148

Synonyms (60)

Synonym
HY-12048
chelerythrine (chloride)
1,2-dimethoxy-12-methyl(1,3)benzodioxolo(5,6-c)phenanthridinium chloride
(1,3)benzodioxolo(5,6-c)phenanthridinium, 1,2-dimethoxy-12-methyl-, chloride
chelerythrine, chloride
chelerythrine, hydroxide, hydrochloride
nsc 36405
einecs 223-444-9
nsc-646662
nsc36405
chelerythrine, hydrochloride
3895-92-9
nsc-36405
[1,6-c]phenanthridinium, 1,2-dimethoxy-12-methyl-, chloride
chelerythrine hydrochloride
EU-0100241
chembl258893 ,
chelerythrine chloride ,
NCGC00093703-01
C 2932
HMS3229C07
HMS3260B04
7ic98tz0pz ,
chelerythrine hcl
unii-7ic98tz0pz
BCP9000516
AKOS016010038
BCPP000287
BCP0726000282
FT-0602998
LP00241
CS-0205
CCG-206741
SCHEMBL195109
1,2-dimethoxy-12-methyl-(1,3)dioxolo(4',5':4,5)benzo(1,2-c)phenanthridin-12-ium chloride
broussonpapyrine chloride
chelerythrinium chloride
NCGC00260926-01
tox21_500241
1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridinium chloride
Q-200824
Q-200825
1,2-dimethoxy-12-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridin-12-ium chloride
chelerythrinechloride
AC-34993
Q-100414
HB0190
mfcd00060717
SR-01000075750-1
1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridiniumchloride
1,2-dimethoxy-12-methyl-[1,3]dioxolo[4',5':4,5]-benzo[1,2-c]phenanthridin-12-ium chloride
chelerythrine cloride
DTXSID70893481
chelerythrine chloride - cas 3895-92-9
AS-17480
HMS3672K05
Q27268347
toddalin chloride
1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;chloride
3895-92-9 (chloride); 34316-15-9 (cation).
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (31)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Potency12.58935.623417.292931.6228AID2323
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
thioredoxin reductaseRattus norvegicus (Norway rat)Potency18.88760.100020.879379.4328AID588453
Microtubule-associated protein tauHomo sapiens (human)Potency12.58930.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency56.23410.28189.721235.4813AID2326
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency9.89950.001530.607315,848.9004AID1224819; AID1224820; AID1224821; AID1224823
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency19.95260.035520.977089.1251AID504332
Bloom syndrome protein isoform 1Homo sapiens (human)Potency3.16230.540617.639296.1227AID2364; AID2528
peripheral myelin protein 22 isoform 1Homo sapiens (human)Potency21.331323.934123.934123.9341AID1967
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency31.62280.001815.663839.8107AID894
DNA polymerase betaHomo sapiens (human)Potency28.18380.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency12.58930.039816.784239.8107AID1454
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency22.38720.010323.856763.0957AID2662
DNA polymerase eta isoform 1Homo sapiens (human)Potency44.66840.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency5.62340.050127.073689.1251AID588590
gemininHomo sapiens (human)Potency2.43900.004611.374133.4983AID463097; AID504364
survival motor neuron protein isoform dHomo sapiens (human)Potency14.12540.125912.234435.4813AID1458
lamin isoform A-delta10Homo sapiens (human)Potency2.99040.891312.067628.1838AID1459; AID1487
neuropeptide S receptor isoform AHomo sapiens (human)Potency19.95260.015812.3113615.5000AID1461
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseElectrophorus electricus (electric eel)IC50 (µMol)3.78000.00000.94539.9400AID697831
AcetylcholinesteraseElectrophorus electricus (electric eel)Ki0.70000.00121.25638.9000AID697835; AID697836
CholinesteraseHomo sapiens (human)IC50 (µMol)10.34000.00001.559910.0000AID697830
Apoptosis regulator Bcl-2Homo sapiens (human)Ki171.00000.00000.19012.9000AID293611
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)1.54000.00000.933210.0000AID697833
AcetylcholinesteraseHomo sapiens (human)Ki0.72000.00001.27869.7300AID697837; AID697838
Cell division control protein 42 homologHomo sapiens (human)IC50 (µMol)100.00002.00005.50009.0000AID437566
Ras-related C3 botulinum toxin substrate 1Homo sapiens (human)IC50 (µMol)53.50002.00004.53337.0000AID437565; AID437569
CholinesteraseEquus caballus (horse)IC50 (µMol)6.33000.00002.22149.4000AID697829
Protein kinase C epsilon typeHomo sapiens (human)IC50 (µMol)0.02400.00010.802910.0000AID325643
Bcl-2-like protein 2Homo sapiens (human)Ki106.00000.00101.25908.1900AID293613
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alanine aminotransferase 1Rattus norvegicus (Norway rat)ID504.00003.40003.70004.0000AID33380
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (318)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processCholinesteraseHomo sapiens (human)
learningCholinesteraseHomo sapiens (human)
negative regulation of cell population proliferationCholinesteraseHomo sapiens (human)
neuroblast differentiationCholinesteraseHomo sapiens (human)
peptide hormone processingCholinesteraseHomo sapiens (human)
response to alkaloidCholinesteraseHomo sapiens (human)
cocaine metabolic processCholinesteraseHomo sapiens (human)
negative regulation of synaptic transmissionCholinesteraseHomo sapiens (human)
response to glucocorticoidCholinesteraseHomo sapiens (human)
response to folic acidCholinesteraseHomo sapiens (human)
choline metabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic processCholinesteraseHomo sapiens (human)
protein polyubiquitinationApoptosis regulator Bcl-2Homo sapiens (human)
apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsApoptosis regulator Bcl-2Homo sapiens (human)
response to xenobiotic stimulusApoptosis regulator Bcl-2Homo sapiens (human)
response to toxic substanceApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of cell growthApoptosis regulator Bcl-2Homo sapiens (human)
response to cytokineApoptosis regulator Bcl-2Homo sapiens (human)
B cell proliferationApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of neuron apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
regulation of calcium ion transportApoptosis regulator Bcl-2Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandApoptosis regulator Bcl-2Homo sapiens (human)
G1/S transition of mitotic cell cycleApoptosis regulator Bcl-2Homo sapiens (human)
ossificationApoptosis regulator Bcl-2Homo sapiens (human)
ovarian follicle developmentApoptosis regulator Bcl-2Homo sapiens (human)
metanephros developmentApoptosis regulator Bcl-2Homo sapiens (human)
branching involved in ureteric bud morphogenesisApoptosis regulator Bcl-2Homo sapiens (human)
behavioral fear responseApoptosis regulator Bcl-2Homo sapiens (human)
B cell homeostasisApoptosis regulator Bcl-2Homo sapiens (human)
B cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
release of cytochrome c from mitochondriaApoptosis regulator Bcl-2Homo sapiens (human)
regulation of cell-matrix adhesionApoptosis regulator Bcl-2Homo sapiens (human)
lymphoid progenitor cell differentiationApoptosis regulator Bcl-2Homo sapiens (human)
B cell lineage commitmentApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of B cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
response to ischemiaApoptosis regulator Bcl-2Homo sapiens (human)
renal system processApoptosis regulator Bcl-2Homo sapiens (human)
melanin metabolic processApoptosis regulator Bcl-2Homo sapiens (human)
regulation of nitrogen utilizationApoptosis regulator Bcl-2Homo sapiens (human)
autophagyApoptosis regulator Bcl-2Homo sapiens (human)
humoral immune responseApoptosis regulator Bcl-2Homo sapiens (human)
DNA damage responseApoptosis regulator Bcl-2Homo sapiens (human)
actin filament organizationApoptosis regulator Bcl-2Homo sapiens (human)
axonogenesisApoptosis regulator Bcl-2Homo sapiens (human)
female pregnancyApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of cell population proliferationApoptosis regulator Bcl-2Homo sapiens (human)
male gonad developmentApoptosis regulator Bcl-2Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressApoptosis regulator Bcl-2Homo sapiens (human)
response to radiationApoptosis regulator Bcl-2Homo sapiens (human)
response to xenobiotic stimulusApoptosis regulator Bcl-2Homo sapiens (human)
response to toxic substanceApoptosis regulator Bcl-2Homo sapiens (human)
post-embryonic developmentApoptosis regulator Bcl-2Homo sapiens (human)
response to iron ionApoptosis regulator Bcl-2Homo sapiens (human)
response to UV-BApoptosis regulator Bcl-2Homo sapiens (human)
response to gamma radiationApoptosis regulator Bcl-2Homo sapiens (human)
regulation of gene expressionApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of autophagyApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of calcium ion transport into cytosolApoptosis regulator Bcl-2Homo sapiens (human)
regulation of glycoprotein biosynthetic processApoptosis regulator Bcl-2Homo sapiens (human)
mesenchymal cell developmentApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of neuron maturationApoptosis regulator Bcl-2Homo sapiens (human)
smooth muscle cell migrationApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of smooth muscle cell migrationApoptosis regulator Bcl-2Homo sapiens (human)
cochlear nucleus developmentApoptosis regulator Bcl-2Homo sapiens (human)
gland morphogenesisApoptosis regulator Bcl-2Homo sapiens (human)
regulation of transmembrane transporter activityApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of ossificationApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of cell growthApoptosis regulator Bcl-2Homo sapiens (human)
melanocyte differentiationApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of cell migrationApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of B cell proliferationApoptosis regulator Bcl-2Homo sapiens (human)
hair follicle morphogenesisApoptosis regulator Bcl-2Homo sapiens (human)
axon regenerationApoptosis regulator Bcl-2Homo sapiens (human)
regulation of protein stabilityApoptosis regulator Bcl-2Homo sapiens (human)
endoplasmic reticulum calcium ion homeostasisApoptosis regulator Bcl-2Homo sapiens (human)
glomerulus developmentApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of cellular pH reductionApoptosis regulator Bcl-2Homo sapiens (human)
regulation of protein localizationApoptosis regulator Bcl-2Homo sapiens (human)
myeloid cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of myeloid cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
T cell differentiation in thymusApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationApoptosis regulator Bcl-2Homo sapiens (human)
osteoblast proliferationApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of osteoblast proliferationApoptosis regulator Bcl-2Homo sapiens (human)
response to nicotineApoptosis regulator Bcl-2Homo sapiens (human)
organ growthApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of multicellular organism growthApoptosis regulator Bcl-2Homo sapiens (human)
cellular response to glucose starvationApoptosis regulator Bcl-2Homo sapiens (human)
response to hydrogen peroxideApoptosis regulator Bcl-2Homo sapiens (human)
neuron maturationApoptosis regulator Bcl-2Homo sapiens (human)
T cell homeostasisApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
CD8-positive, alpha-beta T cell lineage commitmentApoptosis regulator Bcl-2Homo sapiens (human)
ear developmentApoptosis regulator Bcl-2Homo sapiens (human)
regulation of viral genome replicationApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of melanocyte differentiationApoptosis regulator Bcl-2Homo sapiens (human)
retinal cell programmed cell deathApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of retinal cell programmed cell deathApoptosis regulator Bcl-2Homo sapiens (human)
regulation of mitochondrial membrane permeabilityApoptosis regulator Bcl-2Homo sapiens (human)
focal adhesion assemblyApoptosis regulator Bcl-2Homo sapiens (human)
spleen developmentApoptosis regulator Bcl-2Homo sapiens (human)
thymus developmentApoptosis regulator Bcl-2Homo sapiens (human)
digestive tract morphogenesisApoptosis regulator Bcl-2Homo sapiens (human)
oocyte developmentApoptosis regulator Bcl-2Homo sapiens (human)
skeletal muscle fiber developmentApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of skeletal muscle fiber developmentApoptosis regulator Bcl-2Homo sapiens (human)
pigment granule organizationApoptosis regulator Bcl-2Homo sapiens (human)
stem cell developmentApoptosis regulator Bcl-2Homo sapiens (human)
homeostasis of number of cells within a tissueApoptosis regulator Bcl-2Homo sapiens (human)
B cell receptor signaling pathwayApoptosis regulator Bcl-2Homo sapiens (human)
response to glucocorticoidApoptosis regulator Bcl-2Homo sapiens (human)
neuron apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
defense response to virusApoptosis regulator Bcl-2Homo sapiens (human)
establishment of localization in cellApoptosis regulator Bcl-2Homo sapiens (human)
regulation of mitochondrial membrane potentialApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of mitochondrial depolarizationApoptosis regulator Bcl-2Homo sapiens (human)
hematopoietic stem cell differentiationApoptosis regulator Bcl-2Homo sapiens (human)
calcium ion transport into cytosolApoptosis regulator Bcl-2Homo sapiens (human)
T cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of T cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
cellular response to organic substanceApoptosis regulator Bcl-2Homo sapiens (human)
cellular response to hypoxiaApoptosis regulator Bcl-2Homo sapiens (human)
reactive oxygen species metabolic processApoptosis regulator Bcl-2Homo sapiens (human)
dendritic cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
motor neuron apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
cell-cell adhesionApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorApoptosis regulator Bcl-2Homo sapiens (human)
epithelial cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of epithelial cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of G1/S transition of mitotic cell cycleApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of dendritic cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of motor neuron apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of anoikisApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of apoptotic signaling pathwayApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayApoptosis regulator Bcl-2Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageApoptosis regulator Bcl-2Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandApoptosis regulator Bcl-2Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
sprouting angiogenesisCell division control protein 42 homologHomo sapiens (human)
cardiac conduction system developmentCell division control protein 42 homologHomo sapiens (human)
cardiac neural crest cell migration involved in outflow tract morphogenesisCell division control protein 42 homologHomo sapiens (human)
phagocytosis, engulfmentCell division control protein 42 homologHomo sapiens (human)
actin filament organizationCell division control protein 42 homologHomo sapiens (human)
Golgi organizationCell division control protein 42 homologHomo sapiens (human)
regulation of mitotic nuclear divisionCell division control protein 42 homologHomo sapiens (human)
nuclear migrationCell division control protein 42 homologHomo sapiens (human)
establishment or maintenance of cell polarityCell division control protein 42 homologHomo sapiens (human)
integrin-mediated signaling pathwayCell division control protein 42 homologHomo sapiens (human)
protein localizationCell division control protein 42 homologHomo sapiens (human)
regulation of lamellipodium assemblyCell division control protein 42 homologHomo sapiens (human)
positive regulation of lamellipodium assemblyCell division control protein 42 homologHomo sapiens (human)
substantia nigra developmentCell division control protein 42 homologHomo sapiens (human)
actin cytoskeleton organizationCell division control protein 42 homologHomo sapiens (human)
macrophage differentiationCell division control protein 42 homologHomo sapiens (human)
positive regulation of cell growthCell division control protein 42 homologHomo sapiens (human)
positive regulation of cell migrationCell division control protein 42 homologHomo sapiens (human)
positive regulation of pseudopodium assemblyCell division control protein 42 homologHomo sapiens (human)
negative regulation of protein-containing complex assemblyCell division control protein 42 homologHomo sapiens (human)
positive regulation of cytokinesisCell division control protein 42 homologHomo sapiens (human)
regulation of actin cytoskeleton organizationCell division control protein 42 homologHomo sapiens (human)
cell junction assemblyCell division control protein 42 homologHomo sapiens (human)
adherens junction organizationCell division control protein 42 homologHomo sapiens (human)
embryonic heart tube developmentCell division control protein 42 homologHomo sapiens (human)
dendritic cell migrationCell division control protein 42 homologHomo sapiens (human)
neuropilin signaling pathwayCell division control protein 42 homologHomo sapiens (human)
positive regulation of neuron apoptotic processCell division control protein 42 homologHomo sapiens (human)
modulation by host of viral processCell division control protein 42 homologHomo sapiens (human)
establishment of epithelial cell apical/basal polarityCell division control protein 42 homologHomo sapiens (human)
positive regulation of DNA replicationCell division control protein 42 homologHomo sapiens (human)
positive regulation of JNK cascadeCell division control protein 42 homologHomo sapiens (human)
filopodium assemblyCell division control protein 42 homologHomo sapiens (human)
positive regulation of pinocytosisCell division control protein 42 homologHomo sapiens (human)
neuron fate determinationCell division control protein 42 homologHomo sapiens (human)
regulation of filopodium assemblyCell division control protein 42 homologHomo sapiens (human)
positive regulation of filopodium assemblyCell division control protein 42 homologHomo sapiens (human)
regulation of stress fiber assemblyCell division control protein 42 homologHomo sapiens (human)
positive regulation of stress fiber assemblyCell division control protein 42 homologHomo sapiens (human)
establishment of Golgi localizationCell division control protein 42 homologHomo sapiens (human)
positive regulation of synapse structural plasticityCell division control protein 42 homologHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionCell division control protein 42 homologHomo sapiens (human)
regulation of attachment of spindle microtubules to kinetochoreCell division control protein 42 homologHomo sapiens (human)
heart contractionCell division control protein 42 homologHomo sapiens (human)
Wnt signaling pathway, planar cell polarity pathwayCell division control protein 42 homologHomo sapiens (human)
positive regulation of epithelial cell proliferation involved in lung morphogenesisCell division control protein 42 homologHomo sapiens (human)
submandibular salivary gland formationCell division control protein 42 homologHomo sapiens (human)
dendritic spine morphogenesisCell division control protein 42 homologHomo sapiens (human)
cellular response to type II interferonCell division control protein 42 homologHomo sapiens (human)
organelle transport along microtubuleCell division control protein 42 homologHomo sapiens (human)
endothelin receptor signaling pathway involved in heart processCell division control protein 42 homologHomo sapiens (human)
actin filament branchingCell division control protein 42 homologHomo sapiens (human)
positive regulation of intracellular protein transportCell division control protein 42 homologHomo sapiens (human)
regulation of modification of postsynaptic structureCell division control protein 42 homologHomo sapiens (human)
regulation of postsynapse organizationCell division control protein 42 homologHomo sapiens (human)
modification of synaptic structureCell division control protein 42 homologHomo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingCell division control protein 42 homologHomo sapiens (human)
endocytosisCell division control protein 42 homologHomo sapiens (human)
Cdc42 protein signal transductionCell division control protein 42 homologHomo sapiens (human)
positive regulation of lamellipodium assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
actin cytoskeleton organizationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
ruffle organizationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
neuron migrationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of protein phosphorylationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
sphingosine-1-phosphate receptor signaling pathwayRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
inflammatory responseRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cell adhesionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cell-matrix adhesionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
small GTPase-mediated signal transductionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of cell sizeRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
response to woundingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
anatomical structure morphogenesisRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of hydrogen peroxide metabolic processRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of lamellipodium assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of lamellipodium assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of endothelial cell migrationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
negative regulation of fibroblast migrationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of cell-substrate adhesionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cell migrationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
lamellipodium assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
actin filament polymerizationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of cell migrationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of microtubule polymerizationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
ruffle organizationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
negative regulation of interleukin-23 productionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
substrate adhesion-dependent cell spreadingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of Rho protein signal transductionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
intracellular signal transductionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of nitric oxide biosynthetic processRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
respiratory burstRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
hepatocyte growth factor receptor signaling pathwayRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
negative regulation of receptor-mediated endocytosisRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cell motilityRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of stress fiber assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of stress fiber assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
localization within membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of focal adhesion assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
Wnt signaling pathway, planar cell polarity pathwayRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of respiratory burstRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
semaphorin-plexin signaling pathwayRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of neutrophil chemotaxisRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
ruffle assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
engulfment of apoptotic cellRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cell projection assemblyRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cortical cytoskeleton organizationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of neutrophil migrationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
establishment or maintenance of cell polarityRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of cell shapeRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
Rac protein signal transductionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
actin filament organizationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
regulation of actin cytoskeleton organizationRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cell chemotaxisRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
motor neuron axon guidanceRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
MAPK cascadeProtein kinase C epsilon typeHomo sapiens (human)
macrophage activation involved in immune responseProtein kinase C epsilon typeHomo sapiens (human)
protein phosphorylationProtein kinase C epsilon typeHomo sapiens (human)
apoptotic processProtein kinase C epsilon typeHomo sapiens (human)
signal transductionProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of epithelial cell migrationProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of fibroblast migrationProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of cell-substrate adhesionProtein kinase C epsilon typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C epsilon typeHomo sapiens (human)
insulin secretionProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of actin filament polymerizationProtein kinase C epsilon typeHomo sapiens (human)
negative regulation of protein ubiquitinationProtein kinase C epsilon typeHomo sapiens (human)
cell-substrate adhesionProtein kinase C epsilon typeHomo sapiens (human)
lipopolysaccharide-mediated signaling pathwayProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of insulin secretionProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of cytokinesisProtein kinase C epsilon typeHomo sapiens (human)
locomotory exploration behaviorProtein kinase C epsilon typeHomo sapiens (human)
TRAM-dependent toll-like receptor 4 signaling pathwayProtein kinase C epsilon typeHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionProtein kinase C epsilon typeHomo sapiens (human)
response to morphineProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of MAPK cascadeProtein kinase C epsilon typeHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of lipid catabolic processProtein kinase C epsilon typeHomo sapiens (human)
regulation of release of sequestered calcium ion into cytosolProtein kinase C epsilon typeHomo sapiens (human)
cell divisionProtein kinase C epsilon typeHomo sapiens (human)
establishment of localization in cellProtein kinase C epsilon typeHomo sapiens (human)
synaptic transmission, GABAergicProtein kinase C epsilon typeHomo sapiens (human)
regulation of insulin secretion involved in cellular response to glucose stimulusProtein kinase C epsilon typeHomo sapiens (human)
mucus secretionProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of mucus secretionProtein kinase C epsilon typeHomo sapiens (human)
cellular response to ethanolProtein kinase C epsilon typeHomo sapiens (human)
cellular response to prostaglandin E stimulusProtein kinase C epsilon typeHomo sapiens (human)
cellular response to hypoxiaProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of wound healingProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of protein localization to plasma membraneProtein kinase C epsilon typeHomo sapiens (human)
negative regulation of sodium ion transmembrane transporter activityProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of cellular glucuronidationProtein kinase C epsilon typeHomo sapiens (human)
intracellular signal transductionProtein kinase C epsilon typeHomo sapiens (human)
response to ischemiaBcl-2-like protein 2Homo sapiens (human)
spermatogenesisBcl-2-like protein 2Homo sapiens (human)
negative regulation of mitochondrial membrane permeabilityBcl-2-like protein 2Homo sapiens (human)
regulation of apoptotic processBcl-2-like protein 2Homo sapiens (human)
negative regulation of apoptotic processBcl-2-like protein 2Homo sapiens (human)
Sertoli cell proliferationBcl-2-like protein 2Homo sapiens (human)
cellular response to estradiol stimulusBcl-2-like protein 2Homo sapiens (human)
negative regulation of release of cytochrome c from mitochondriaBcl-2-like protein 2Homo sapiens (human)
cellular response to amyloid-betaBcl-2-like protein 2Homo sapiens (human)
cellular response to glycineBcl-2-like protein 2Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl-2-like protein 2Homo sapiens (human)
release of cytochrome c from mitochondriaBcl-2-like protein 2Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl-2-like protein 2Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl-2-like protein 2Homo sapiens (human)
glucose catabolic processBcl2-associated agonist of cell death Homo sapiens (human)
apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsBcl2-associated agonist of cell death Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of autophagyBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of mitochondrial membrane potentialBcl2-associated agonist of cell death Homo sapiens (human)
cytokine-mediated signaling pathwayBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of insulin secretionBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of glucokinase activityBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusBcl2-associated agonist of cell death Homo sapiens (human)
glucose homeostasisBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
type B pancreatic cell proliferationBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of B cell differentiationBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of T cell differentiationBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of proteolysisBcl2-associated agonist of cell death Homo sapiens (human)
ADP metabolic processBcl2-associated agonist of cell death Homo sapiens (human)
ATP metabolic processBcl2-associated agonist of cell death Homo sapiens (human)
regulation of mitochondrial membrane permeabilityBcl2-associated agonist of cell death Homo sapiens (human)
pore complex assemblyBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of epithelial cell proliferationBcl2-associated agonist of cell death Homo sapiens (human)
cellular response to mechanical stimulusBcl2-associated agonist of cell death Homo sapiens (human)
cellular response to nicotineBcl2-associated agonist of cell death Homo sapiens (human)
cellular response to lipidBcl2-associated agonist of cell death Homo sapiens (human)
cellular response to hypoxiaBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaBcl2-associated agonist of cell death Homo sapiens (human)
extrinsic apoptotic signaling pathwayBcl2-associated agonist of cell death Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl2-associated agonist of cell death Homo sapiens (human)
intrinsic apoptotic signaling pathwayBcl2-associated agonist of cell death Homo sapiens (human)
activation of cysteine-type endopeptidase activityBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stressBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of type B pancreatic cell developmentBcl2-associated agonist of cell death Homo sapiens (human)
release of cytochrome c from mitochondriaBcl2-associated agonist of cell death Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (55)

Processvia Protein(s)Taxonomy
amyloid-beta bindingCholinesteraseHomo sapiens (human)
catalytic activityCholinesteraseHomo sapiens (human)
acetylcholinesterase activityCholinesteraseHomo sapiens (human)
cholinesterase activityCholinesteraseHomo sapiens (human)
protein bindingCholinesteraseHomo sapiens (human)
hydrolase activity, acting on ester bondsCholinesteraseHomo sapiens (human)
enzyme bindingCholinesteraseHomo sapiens (human)
choline bindingCholinesteraseHomo sapiens (human)
identical protein bindingCholinesteraseHomo sapiens (human)
protease bindingApoptosis regulator Bcl-2Homo sapiens (human)
protein bindingApoptosis regulator Bcl-2Homo sapiens (human)
channel activityApoptosis regulator Bcl-2Homo sapiens (human)
channel inhibitor activityApoptosis regulator Bcl-2Homo sapiens (human)
ubiquitin protein ligase bindingApoptosis regulator Bcl-2Homo sapiens (human)
identical protein bindingApoptosis regulator Bcl-2Homo sapiens (human)
sequence-specific DNA bindingApoptosis regulator Bcl-2Homo sapiens (human)
protein heterodimerization activityApoptosis regulator Bcl-2Homo sapiens (human)
BH3 domain bindingApoptosis regulator Bcl-2Homo sapiens (human)
protein phosphatase 2A bindingApoptosis regulator Bcl-2Homo sapiens (human)
molecular adaptor activityApoptosis regulator Bcl-2Homo sapiens (human)
DNA-binding transcription factor bindingApoptosis regulator Bcl-2Homo sapiens (human)
BH domain bindingApoptosis regulator Bcl-2Homo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
GTPase activityCell division control protein 42 homologHomo sapiens (human)
G protein activityCell division control protein 42 homologHomo sapiens (human)
protein bindingCell division control protein 42 homologHomo sapiens (human)
GTP bindingCell division control protein 42 homologHomo sapiens (human)
protein kinase bindingCell division control protein 42 homologHomo sapiens (human)
GTP-dependent protein bindingCell division control protein 42 homologHomo sapiens (human)
mitogen-activated protein kinase kinase kinase bindingCell division control protein 42 homologHomo sapiens (human)
thioesterase bindingCell division control protein 42 homologHomo sapiens (human)
GBD domain bindingCell division control protein 42 homologHomo sapiens (human)
apolipoprotein A-I receptor bindingCell division control protein 42 homologHomo sapiens (human)
identical protein bindingCell division control protein 42 homologHomo sapiens (human)
ubiquitin protein ligase activityCell division control protein 42 homologHomo sapiens (human)
GTPase activityRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
G protein activityRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
protein bindingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
GTP bindingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
enzyme bindingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
protein kinase bindingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
thioesterase bindingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
protein-containing complex bindingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
Rho GDP-dissociation inhibitor bindingRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
actin monomer bindingProtein kinase C epsilon typeHomo sapiens (human)
protein kinase activityProtein kinase C epsilon typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C epsilon typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C epsilon typeHomo sapiens (human)
diacylglycerol-dependent, calcium-independent serine/threonine kinase activityProtein kinase C epsilon typeHomo sapiens (human)
protein bindingProtein kinase C epsilon typeHomo sapiens (human)
ATP bindingProtein kinase C epsilon typeHomo sapiens (human)
enzyme activator activityProtein kinase C epsilon typeHomo sapiens (human)
enzyme bindingProtein kinase C epsilon typeHomo sapiens (human)
signaling receptor activator activityProtein kinase C epsilon typeHomo sapiens (human)
ethanol bindingProtein kinase C epsilon typeHomo sapiens (human)
metal ion bindingProtein kinase C epsilon typeHomo sapiens (human)
14-3-3 protein bindingProtein kinase C epsilon typeHomo sapiens (human)
protein serine kinase activityProtein kinase C epsilon typeHomo sapiens (human)
protein bindingBcl-2-like protein 2Homo sapiens (human)
identical protein bindingBcl-2-like protein 2Homo sapiens (human)
protein-containing complex bindingBcl-2-like protein 2Homo sapiens (human)
disordered domain specific bindingBcl-2-like protein 2Homo sapiens (human)
BH domain bindingBcl-2-like protein 2Homo sapiens (human)
protein bindingBcl2-associated agonist of cell death Homo sapiens (human)
phospholipid bindingBcl2-associated agonist of cell death Homo sapiens (human)
lipid bindingBcl2-associated agonist of cell death Homo sapiens (human)
cysteine-type endopeptidase activator activity involved in apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
protein kinase bindingBcl2-associated agonist of cell death Homo sapiens (human)
protein phosphatase bindingBcl2-associated agonist of cell death Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (65)

Processvia Protein(s)Taxonomy
extracellular regionCholinesteraseHomo sapiens (human)
nuclear envelope lumenCholinesteraseHomo sapiens (human)
endoplasmic reticulum lumenCholinesteraseHomo sapiens (human)
blood microparticleCholinesteraseHomo sapiens (human)
plasma membraneCholinesteraseHomo sapiens (human)
extracellular spaceCholinesteraseHomo sapiens (human)
mitochondrial outer membraneApoptosis regulator Bcl-2Homo sapiens (human)
endoplasmic reticulum membraneApoptosis regulator Bcl-2Homo sapiens (human)
nucleusApoptosis regulator Bcl-2Homo sapiens (human)
cytoplasmApoptosis regulator Bcl-2Homo sapiens (human)
mitochondrionApoptosis regulator Bcl-2Homo sapiens (human)
mitochondrial outer membraneApoptosis regulator Bcl-2Homo sapiens (human)
endoplasmic reticulumApoptosis regulator Bcl-2Homo sapiens (human)
cytosolApoptosis regulator Bcl-2Homo sapiens (human)
membraneApoptosis regulator Bcl-2Homo sapiens (human)
nuclear membraneApoptosis regulator Bcl-2Homo sapiens (human)
myelin sheathApoptosis regulator Bcl-2Homo sapiens (human)
BAD-BCL-2 complexApoptosis regulator Bcl-2Homo sapiens (human)
protein-containing complexApoptosis regulator Bcl-2Homo sapiens (human)
pore complexApoptosis regulator Bcl-2Homo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
centrosomeCell division control protein 42 homologHomo sapiens (human)
Golgi membraneCell division control protein 42 homologHomo sapiens (human)
storage vacuoleCell division control protein 42 homologHomo sapiens (human)
cytoplasmCell division control protein 42 homologHomo sapiens (human)
endoplasmic reticulum membraneCell division control protein 42 homologHomo sapiens (human)
cytosolCell division control protein 42 homologHomo sapiens (human)
plasma membraneCell division control protein 42 homologHomo sapiens (human)
cell-cell junctionCell division control protein 42 homologHomo sapiens (human)
focal adhesionCell division control protein 42 homologHomo sapiens (human)
membraneCell division control protein 42 homologHomo sapiens (human)
secretory granuleCell division control protein 42 homologHomo sapiens (human)
filopodiumCell division control protein 42 homologHomo sapiens (human)
midbodyCell division control protein 42 homologHomo sapiens (human)
leading edge membraneCell division control protein 42 homologHomo sapiens (human)
cytoplasmic ribonucleoprotein granuleCell division control protein 42 homologHomo sapiens (human)
neuron projectionCell division control protein 42 homologHomo sapiens (human)
neuronal cell bodyCell division control protein 42 homologHomo sapiens (human)
dendritic spineCell division control protein 42 homologHomo sapiens (human)
apical part of cellCell division control protein 42 homologHomo sapiens (human)
phagocytic vesicleCell division control protein 42 homologHomo sapiens (human)
spindle midzoneCell division control protein 42 homologHomo sapiens (human)
extracellular exosomeCell division control protein 42 homologHomo sapiens (human)
mitotic spindleCell division control protein 42 homologHomo sapiens (human)
Schaffer collateral - CA1 synapseCell division control protein 42 homologHomo sapiens (human)
glutamatergic synapseCell division control protein 42 homologHomo sapiens (human)
Golgi transport complexCell division control protein 42 homologHomo sapiens (human)
protein-containing complexCell division control protein 42 homologHomo sapiens (human)
dendritic spineCell division control protein 42 homologHomo sapiens (human)
plasma membraneCell division control protein 42 homologHomo sapiens (human)
actin filamentRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
postsynapseRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
glutamatergic synapseRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
nucleusRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cytoplasmRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
endoplasmic reticulum membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
trans-Golgi networkRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cytosolRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
plasma membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
focal adhesionRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cell cortexRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
lamellipodiumRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
secretory granule membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
ruffle membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cytoplasmic ribonucleoprotein granuleRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
melanosomeRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
NADPH oxidase complexRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
dendritic spineRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
recycling endosome membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
extracellular exosomeRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
ficolin-1-rich granule membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cytoplasmic vesicleRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
plasma membraneRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
dendritic spineRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
cytoskeletonRas-related C3 botulinum toxin substrate 1Homo sapiens (human)
Golgi apparatusProtein kinase C epsilon typeHomo sapiens (human)
nucleusProtein kinase C epsilon typeHomo sapiens (human)
cytoplasmProtein kinase C epsilon typeHomo sapiens (human)
mitochondrionProtein kinase C epsilon typeHomo sapiens (human)
endoplasmic reticulumProtein kinase C epsilon typeHomo sapiens (human)
cytosolProtein kinase C epsilon typeHomo sapiens (human)
plasma membraneProtein kinase C epsilon typeHomo sapiens (human)
intracellular membrane-bounded organelleProtein kinase C epsilon typeHomo sapiens (human)
intermediate filament cytoskeletonProtein kinase C epsilon typeHomo sapiens (human)
synapseProtein kinase C epsilon typeHomo sapiens (human)
perinuclear region of cytoplasmProtein kinase C epsilon typeHomo sapiens (human)
cell peripheryProtein kinase C epsilon typeHomo sapiens (human)
cytosolBcl-2-like protein 2Homo sapiens (human)
Bcl-2 family protein complexBcl-2-like protein 2Homo sapiens (human)
mitochondrial outer membraneBcl-2-like protein 2Homo sapiens (human)
mitochondrionBcl2-associated agonist of cell death Homo sapiens (human)
mitochondrial outer membraneBcl2-associated agonist of cell death Homo sapiens (human)
cytosolBcl2-associated agonist of cell death Homo sapiens (human)
BAD-BCL-2 complexBcl2-associated agonist of cell death Homo sapiens (human)
cytosolBcl2-associated agonist of cell death Homo sapiens (human)
mitochondrionBcl2-associated agonist of cell death Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (157)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID697837Competitive inhibition of human AChE using acetyl thiocholine iodide as substrate by Lineweaver-Burk double-reciprocal analysis2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224805Delta TM value showing the stabilisation of VRK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID33384Effect of cysteine on alanine aminotransferase inhibition by the compound at 10E-51981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID1224774Delta TM value showing the stabilisation of p38beta produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224807Delta TM value showing the stabilisation of YSK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID33383Effect of thioethanol on alanine aminotransferase inhibition by the compound at 10E-51981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID646561Antibacterial activity against Staphylococcus epidermidis ATCC 35984 assessed as modification of bacterial surface protein pattern at 4 uM by zymographic analysis2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID524796Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1224794Delta TM value showing the stabilisation of RSK2b produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224753Delta TM value showing the stabilisation of CAMK2D produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID18995The stability constant of adduct formation for cysteine at pH 5.681981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID1236962Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Jul-15, Volume: 25, Issue:14
Antiproliferative activity of O4-benzo[c]phenanthridine alkaloids against HCT-116 and HL-60 tumor cells.
AID1224751Delta TM value showing the stabilisation of CAMK2A produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID33385Effect of glutathione on alanine aminotransferase inhibition by the compound at 10E-51981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID646550Antibacterial activity against Staphylococcus epidermidis ATCC 35984 assessed as inhibition of biofilm formation after 24 hrs by crystal violet staining2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID1224787Delta TM value showing the stabilisation of PIM2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID646559Antibacterial activity against Staphylococcus aureus ATCC 6538P assessed as change in bacterial surface protein level at sub-MIC by zymographic analysis2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID1224785Delta TM value showing the stabilisation of PDK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID324393Induction of light chain 3-GFP level in human H4 cells at 6.5 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1224759Delta TM value showing the stabilisation of CDKL1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID379845Growth inhibition of human HeLa S3 cells after 72 hrs1999Journal of natural products, Jun, Volume: 62, Issue:6
Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid.
AID1224777Delta TM value showing the stabilisation of MST4(1) produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID697831Inhibition of electric eel AChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697835Competitive inhibition of electric eel AChE using acetyl thiocholine iodide as substrate by Lineweaver-Burk double-reciprocal analysis2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224801Delta TM value showing the stabilisation of MST1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID367138Inhibition of Bz-ATP-induced IL1-beta release in LPS/IFN-gamma-differentiated human THP1 cells at 1 uM by ELISA2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.
AID325540Inhibition of PKA2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224772Delta TM value showing the stabilisation of MAP2K6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224752Delta TM value showing the stabilisation of CAMK2B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID324580Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 4 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID33379Concentration for complete inactivation of alanine aminotransferase1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID1224790Delta TM value showing the stabilisation of PLK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224802Delta TM value showing the stabilisation of TNIK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID18999The stability constant of adduct formation for glutathione at pH 5.681981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID33386Effect of thioethanol on alanine aminotransferase inhibition by the compound at 10E-51981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID1224783Delta TM value showing the stabilisation of PAK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID33381Effect of cysteine on alanine aminotransferase inhibition by the compound at 10E-51981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID524794Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1236963Antiproliferative activity against human HL60 cells assessed as inhibition of cell viability after 48 hrs by WST-1 assay2015Bioorganic & medicinal chemistry letters, Jul-15, Volume: 25, Issue:14
Antiproliferative activity of O4-benzo[c]phenanthridine alkaloids against HCT-116 and HL-60 tumor cells.
AID397122Inhibition of HIV1 RT
AID1224793Delta TM value showing the stabilisation of RSK2a produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID379857Toxicity against mouse P388 cells xenografted CDF1 mouse assessed as survival time at 6.25 mg/kg, iv1999Journal of natural products, Jun, Volume: 62, Issue:6
Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid.
AID1224797Delta TM value showing the stabilisation of MPSK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224776Delta TM value showing the stabilisation of ERK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID18997The stability constant of adduct formation for cysteine at pH 6.251981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID324582Increase in long-lived protein degradation in human H4 cells after 1 hr relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1224762Delta TM value showing the stabilisation of CLK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID646553Antibacterial activity against Staphylococcus epidermidis ATCC 35984 by broth microdilution method2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID1224779Delta TM value showing the stabilisation of NEK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224800Delta TM value showing the stabilisation of MST4 (2) produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224750Delta TM value showing the stabilisation of CAMK1G produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID33380Inhibitory activity against alanine aminotransferase was measured1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID1224803Delta TM value showing the stabilisation of PBK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID524790Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1224775Delta TM value showing the stabilisation of ERK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224749Delta TM value showing the stabilisation of CAMK1D produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224786Delta TM value showing the stabilisation of PIM1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224767Delta TM value showing the stabilisation of DAPK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID437570Inhibition of Rac GTPase activation in Rac1b overexpressing human HEK293 cells at 50 uM after 5 mins by G-LISA assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
AID324445Increase in light chain 3-GFP+ autophagosome vesicle number per cell in human H4 cells at 6.5 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID521210Ratio of EC50 for mouse astrocytes to EC50 for mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID437565Inhibition of Rac1 GTPase activity assessed as incorporation of BODIPY-GTP after 40 mins by nucleotide binding competition assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
AID379849Antitumor activity against mouse P388 cells xenografted CDF1 mouse at 25 mg/kg, iv administered on day 1 after 30 days relative to control1999Journal of natural products, Jun, Volume: 62, Issue:6
Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid.
AID325541Inhibition of PKC2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224748Delta TM value showing the stabilisation of AMPKA2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224784Delta TM value showing the stabilisation of PCTK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID324583Increase in long-lived protein degradation in human H4 cells after 2 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1224764Delta TM value showing the stabilisation of CK1G1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID379851Antitumor activity against mouse P388 cells xenografted CDF1 mouse at 6.25 mg/kg, iv administered on day 1 after 30 days relative to control1999Journal of natural products, Jun, Volume: 62, Issue:6
Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid.
AID379856Toxicity against mouse P388 cells xenografted CDF1 mouse assessed as survival time at 12.5 mg/kg, iv1999Journal of natural products, Jun, Volume: 62, Issue:6
Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid.
AID437568Inhibition of Rac1b GTPase activity assessed as incorporation of BODIPY-GTP at 50 uM after 40 mins by nucleotide binding competition assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
AID524792Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID324584Increase in long-lived protein degradation in human H4 cells after 4 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324579Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 2 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID697839Inhibition of HFIP-induced amyloid beta (1 to 40) aggregation after 45 mins by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224761Delta TM value showing the stabilisation of CLK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224768Delta TM value showing the stabilisation of DMPK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224769Delta TM value showing the stabilisation of GSK3B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID524791Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID697844Inhibition of amyloid beta (1 to 40) aggregation assessed as induction of disaggregation treated 45 mins after formation of aggregates by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224760Delta TM value showing the stabilisation of CHEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224766Delta TM value showing the stabilisation of CK1G3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID324497Increase in light chain 3-GFP+ autophagosome vesicle area per cell in human H4 cells at 6.5 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1224770Delta TM value showing the stabilisation of JAK1~B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID524793Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID697849Inhibition of electric eel AChE-mediated amyloid beta (1 to 40) fibril formation at 5 uM after 24 hrs by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224755Delta TM value showing the stabilisation of CAMK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID19005The stability constant of adduct formation for thioethanol at pH 6.251981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID1224799Delta TM value showing the stabilisation of NDR1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224795Delta TM value showing the stabilisation of SLK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID646556Antibacterial activity against Staphylococcus epidermidis ATCC 35984 assessed as inhibition of planktonic growth at sub-MIC measured up to 25 hrs2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID1224789Delta TM value showing the stabilisation of PLK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID325643Inhibition of PKCepsilon2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID404304Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
AID324549Increase in light chain 3-GFP+ autophagosome vesicle intensity per cell in human H4 cells at 6.5 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID697833Inhibition of human AChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID293612Displacement of Flu-Bak peptide from recombinant antiapoptotic Bcl-XL protein by fluorescence polarization assay2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1.
AID1224778Delta TM value showing the stabilisation of NEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224763Delta TM value showing the stabilisation of CLK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID697841Inhibition of HFIP-induced amyloid beta (1 to 40) aggregation at 10 uM after 45 mins by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224756Delta TM value showing the stabilisation of CAMKK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224782Delta TM value showing the stabilisation of PAK5 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224758Delta TM value showing the stabilisation of CDK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID247402Growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program2005Journal of medicinal chemistry, Mar-10, Volume: 48, Issue:5
CHMIS-C: a comprehensive herbal medicine information system for cancer.
AID524795Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID437567Selectivity of IC50 for Rac1 GTPase activity to IC50 for Rac1b GTPase activity2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
AID521208Antiproliferative activity against mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID646554Antibacterial activity against Staphylococcus aureus ATCC 6538P by broth microdilution method2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID379855Toxicity against mouse P388 cells xenografted CDF1 mouse assessed as survival time at 25 mg/kg, iv1999Journal of natural products, Jun, Volume: 62, Issue:6
Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid.
AID697836Uncompetitive inhibition of electric eel AChE using acetyl thiocholine iodide as substrate by Lineweaver-Burk double-reciprocal analysis2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID247524In vitro cytotoxicity for human ovarian tumor A2780 cells2005Journal of medicinal chemistry, Jul-14, Volume: 48, Issue:14
Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
AID293611Displacement of Flu-Bak peptide from recombinant antiapoptotic Bcl2 protein by fluorescence polarization assay2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1.
AID697830Inhibition of human BChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID646551Antibacterial activity against Staphylococcus aureus ATCC 6538P assessed as inhibition of biofilm formation after 24 hrs by crystal violet staining2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID389997Displacement of fluorescein-labeled Bak-BH3 peptide from human Bcl-XL by fluorescence polarization assay2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Structure-activity relationship studies of phenanthridine-based Bcl-XL inhibitors.
AID1224765Delta TM value showing the stabilisation of CK1G2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224796Delta TM value showing the stabilisation of LOK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224804Delta TM value showing the stabilisation of VRK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID437569Inhibition of Rac1b GTPase activity assessed as incorporation of BODIPY-GTP after 40 mins by nucleotide binding competition assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
AID379850Antitumor activity against mouse P388 cells xenografted CDF1 mouse at 12.5 mg/kg, iv administered on day 1 after 30 days relative to control1999Journal of natural products, Jun, Volume: 62, Issue:6
Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid.
AID1224773Delta TM value showing the stabilisation of ASK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID697850Inhibition of electric eel AChE-mediated amyloid beta (1 to 40) fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697848Inhibition of electric eel AChE-mediated amyloid beta (1 to 40) fibril formation at 1 uM after 24 hrs by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224798Delta TM value showing the stabilisation of DRAK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224771Delta TM value showing the stabilisation of MEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID697851Inhibition of electric eel AChE-mediated amyloid beta (1 to 40) fibril formation at 100 uM after 24 hrs by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID324585Increase in long-lived protein degradation in human H4 cells after 24 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID33382Effect of glutathione on alanine aminotransferase inhibition by the compound at 10E-51981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID646552Antibacterial activity against Staphylococcus epidermidis ATCC 35984 incubated in drug free medium for 18 hrs after MIC determination by broth microdilution method2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID19001The stability constant of adduct formation for glutathione at pH 6.251981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID19003The stability constant of adduct formation for thioethanol at pH 5.681981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids.
AID437566Inhibition of Cdc42 GTPase activity assessed as incorporation of BODIPY-GTP after 40 mins by nucleotide binding competition assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
AID437564Inhibition of Cdc42 GTPase activity assessed as incorporation of BODIPY-GTP at 50 uM after 40 mins by nucleotide binding competition assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
AID1224792Delta TM value showing the stabilisation of RIOK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID324581Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 8 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID521209Antiproliferative activity against mouse astrocyte cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1224788Delta TM value showing the stabilisation of PIM3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID238004Binding affinity towards salmon testes DNA2005Journal of medicinal chemistry, Jul-14, Volume: 48, Issue:14
Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
AID1224754Delta TM value showing the stabilisation of CAMK2G produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID697829Inhibition of horse BChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID646557Antibacterial activity against Staphylococcus aureus ATCC 6538P assessed as change in bacterial surface protein level at sub-MIC by SDS-PAGE analysis2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID293613Displacement of Flu-Bak peptide from recombinant antiapoptotic Bcl-w protein by fluorescence polarization assay2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1.
AID1224791Delta TM value showing the stabilisation of PRKACA produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224806Delta TM value showing the stabilisation of VRK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID437563Inhibition of Rac1 GTPase activity assessed as incorporation of BODIPY-GTP at 50 uM after 40 mins by nucleotide binding competition assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
AID697838Uncompetitive inhibition of human AChE using acetyl thiocholine iodide as substrate by Lineweaver-Burk double-reciprocal analysis2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224781Delta TM value showing the stabilisation of PAK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID646549Antibacterial activity against Staphylococcus aureus ATCC 6538P assessed as inhibition of planktonic growth at sub-MIC measured up to 25 hrs2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1224757Delta TM value showing the stabilisation of CDK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID646555Antibacterial activity against Staphylococcus aureus ATCC 6538P incubated in drug free medium for 18 hrs after MIC determination by broth microdilution method2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds.
AID1224780Delta TM value showing the stabilisation of OSR1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.88)18.7374
1990's1 (5.88)18.2507
2000's11 (64.71)29.6817
2010's3 (17.65)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.14 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.44 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]